The COVID-19 and Cancer Consortium
CCC19 is a consortium of 120+ organizations that are working together to collect data about patients with cancer who have been diagnosed with COVID-19.
Related Articles
Program Guide – ASCO Meeting Program Guide
Yuan Yuan, Irene Kang, Jin Sun Bitar, Andrew Davis, Christie Hilton, Minxuan Huang, Michael Thompson, Jacob Mercer, Stephen Shiao, Eric Vail Cedars-Sinai Medical Center, City…
Program Guide – ASCO Meeting Program Guide
Christine Ho Roswell Park Comprehensive Cancer Center, Buffalo, NY Christine Ho, Paul K. Wallace, Kristopher Attwood, Sarah Parker, Hemn Mohammadpour, Megan Herr, George Chen, Joseph…
Program Guide – ASCO Meeting Program Guide
Ghulam Rehman Mohyuddin University of Utah, Salt Lake City, UT Ghulam Rehman Mohyuddin, Jennifer M. Ahlstrom, Cynthia Chmielewski, Nathan W. Sweeney, Thomas H. Molina, Christian…
Program Guide – ASCO Meeting Program Guide
Sridurga Mithraprabhu Alfred Hospital / Monash University, Melbourne, Australia Sridurga Mithraprabhu, John Reynolds, Rose Turner, Anna Kalff, Krystal Bergin, HANG QUACH, Tiffany Khong, Brian G.…
Program Guide – ASCO Meeting Program Guide
Suresh Ramalingam Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute Suresh Ramalingam, Terufumi Kato, Xiaorong Dong, Myung-Ju Ahn, Le-Van…
Program Guide – ASCO Meeting Program Guide
Joseph Greer Massachusetts General Hospital, Harvard Medical School Joseph Greer, Chardria Trotter, Vicki Jackson, Simone Rinaldi, Mihir Kamdar, Areej El-Jawahri, Nora Horick, Kedie Pintro, Dustin…
#PallOnc – Healthcare Social Media Analytics and Transcripts
In an effort to ensure that oncology professionals are providing the highest-quality care, ASCO strives to offer resources and forums to discuss the best
Program Guide – ASCO Meeting Program Guide
Christian Blank Netherlands Cancer Institute (NKI-AVL), Department of Medical Oncology Christian Blank, Minke Lucas, Richard Scolyer, Bart van de Wiel, Alexander Menzies, Marta Lopez-Yurda, Alexander…
Program Guide – ASCO Meeting Program Guide
Jens Hoeppner, Thomas Brunner, Florian Lordick, Claudia Schmoor, Birte Kulemann, Ulf Peter Neumann, Gunnar Folprech t, Tobias Keck, Frank Benedix, Maximilan Schmeding, Ernst Reitsamer, Christiane…
RAS/RAFlandscape in monoclonal plasma cell conditions.
Key Points. RAS/RAF mutations are present in up to 61% of patients with multiple myelomaMost of them are subclonal, in agreement with a secondary event